Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,272
Sort by:
Pharmaceutical Contract Manufacturing Global Market – Forecast To 2027
US$ 4,950.00
... role in securing client relationships that can lead to commercial scale manufacturing contracts. Pharmaceutical contract manufacturing market by application is segmented as Oncology, Central nervous system, Cardiovascular disorder, Infectious ...
May 2021
531 pages
Ankylosing Spondylitis - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ankylosing Spondylitis (Bekhterev's Disease) The report also ...
May 2021
80 pages
Anthrax - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Anthrax - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Anthrax development. The report provides detailed ...
May 2021
60 pages
Aplastic Anemia - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Aplastic Anemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Aplastic Anemia development. The report provides ...
May 2021
60 pages
Bacteremia - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Bacteremia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bacteremia development. The report provides detailed ...
May 2021
60 pages
Diabetic gastroparesis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Diabetic Gastroparesis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Gastroparesis development. The report provides ...
May 2021
70 pages
Gastrointestinal Stromal Tumors - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Gastrointestinal Stromal Tumor (GIST) The report also ...
May 2021
60 pages
Vitiligo - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Vitiligo - Pipeline Insight, 2019 The report also ...
May 2021
70 pages
Axial spondyloarthritis - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Axial Spondyloarthritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Axial Spondyloarthritis development. The report provides ...
May 2021
80 pages
Bacterial vaginosis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Bacterial Vaginosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bacterial Vaginosis development. The report provides ...
May 2021
60 pages
Hepatitis D - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Hepatitis D - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hepatitis D development. The report provides ...
May 2021
60 pages
Hyperphosphatemia - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Hyperphosphatemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperphosphatemia development. The report provides detailed ...
May 2021
60 pages
Influenza A virus H5N1 subtype - Pipeline Insight, 2021
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Influenza A Infections The report also ...
May 2021
60 pages
Kaposi's sarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Kaposi's Sarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Kaposi's Sarcoma development. The report provides ...
May 2021
60 pages
Nocturia - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Nocturia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Nocturia development. The report provides detailed ...
May 2021
60 pages
Nonalcoholic Steatohepatitis - Pipeline Insight, 2021
US$ 3,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Non-Alcoholic Steatohepatitis (NASH) The report also ...
May 2021
230 pages
Open-angle glaucoma - Pipeline Insight, 2021
US$ 2,000.00
... clients within 72 Hours 'Open-Angle Glaucoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Open-Angle Glaucoma development. The report provides ...
May 2021
80 pages
Paroxysmal nocturnal haemoglobinuria - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Paroxysmal Nocturnal Hemoglobinuria The report also ...
May 2021
100 pages
Peripheral Arterial Disease - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) The report also ...
May 2021
60 pages
Postmenopausal osteoporosis - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Post Menopausal Osteoporosis The report also ...
May 2021
60 pages
Psoriatic arthritis - Pipeline Insight, 2021
US$ 2,000.00
... clients within 72 Hours 'Psoriatic Arthritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Psoriatic Arthritis development. The report provides ...
May 2021
80 pages
Retinitis Pigmentosa - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Retinitis Pigmentosa (Retinitis) The report also ...
May 2021
80 pages
Thyroid cancer - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Thyroid Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Thyroid Cancer development. The report provides ...
May 2021
60 pages
Tinnitus - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Tinnitus - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tinnitus development. The report provides detailed ...
May 2021
60 pages
Traveler’s diarrhea - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Traveler's Diarrhea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Traveler's Diarrhea development. The report provides ...
May 2021
60 pages
Vascular Dementia - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Vascular Dementia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vascular Dementia development. The report provides ...
May 2021
60 pages
Atopic Dermatitis - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Atopic Dermatitis – Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipelin...
May 2021
120 pages
Atrial fibrillation - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Atrial fibrillation - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipelin...
May 2021
70 pages
Chagas disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Chagas disease – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs...
May 2021
60 pages
Crohn’s Disease - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Crohn’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 80+ companies and 90+ pipeline dr...
May 2021
150 pages
Irritable bowel syndrome - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Irritable bowel syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 24+ companies and 24+ pi...
May 2021
60 pages
Leigh disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Leigh disease - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...
May 2021
60 pages
Major Depressive Disorder - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ p...
May 2021
120 pages
Pneumococcal infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pneumococcal infections – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pip...
May 2021
60 pages
Polycystic ovary syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Polycystic ovary syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pip...
May 2021
60 pages
Pyoderma gangrenosum - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pyoderma gangrenosum - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
May 2021
60 pages
Sepsis - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sepsis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Se...
May 2021
80 pages
Ulcerative Colitis - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Ulcerative Colitis - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 110+ pipeli...
May 2021
200 pages
Vasomotor Symptoms - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Vasomotor Symptoms - Pipeline Insight, 2021,” report provides comprehensive insights about 9+ companies and 9+ pipeline d...
May 2021
60 pages
